Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


14.10.2019

2 Alzheimers Dement
1 Dement Geriatr Cogn Disord
12 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neurol
1 Nat Neurosci
5 Neurobiol Aging
1 Neuropsychology
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. EHRHARDT S, Porsteinsson AP, Munro CA, Rosenberg PB, et al
    Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
    Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35112.
    PubMed     Text format     Abstract available

  2. OGINO E, Manly JJ, Schupf N, Mayeux R, et al
    Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults.
    Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35136.
    PubMed     Text format     Abstract available


    Dement Geriatr Cogn Disord

  3. CHEN TB, Weng SC, Chou YY, Lee YS, et al
    Predictors of Mortality in the Oldest Old Patients with Newly Diagnosed Alzheimer Disease in a Residential Aged Care Facility.
    Dement Geriatr Cogn Disord. 2019 Oct 10:1-12. doi: 10.1159/000503059.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  4. ZHOU G, Zhao X, Lou Z, Zhou S, et al
    Impaired Cerebral Autoregulation in Alzheimer's Disease: A Transcranial Doppler Study.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190296. doi: 10.3233/JAD-190296.
    PubMed     Text format     Abstract available

  5. ABU-RUMEILEH S, Mometto N, Bartoletti-Stella A, Polischi B, et al
    Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    J Alzheimers Dis. 2018 Oct 5. pii: JAD180409. doi: 10.3233/JAD-180409.
    PubMed     Text format     Abstract available

  6. TEIPEL SJ, Kuper-Smith JO, Bartels C, Brosseron F, et al
    Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.
    J Alzheimers Dis. 2019 Oct 1. pii: JAD190446. doi: 10.3233/JAD-190446.
    PubMed     Text format     Abstract available

  7. GOLDSTEIN FC, Loring DW, Thomas T, Saleh S, et al
    Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 1. pii: JAD190468. doi: 10.3233/JAD-190468.
    PubMed     Text format     Abstract available

  8. KANG DE, Woo JA
    Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 25. pii: JAD190585. doi: 10.3233/JAD-190585.
    PubMed     Text format     Abstract available

  9. LIU XX, Jiao B, Liao XX, Guo LN, et al
    Analysis of Salivary Microbiome in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190587. doi: 10.3233/JAD-190587.
    PubMed     Text format     Abstract available

  10. LIU X, Hebron ML, Mulki S, Wang C, et al
    Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 28. pii: JAD190635. doi: 10.3233/JAD-190635.
    PubMed     Text format     Abstract available

  11. AULSTON B, Liu Q, Mante M, Florio J, et al
    Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190656. doi: 10.3233/JAD-190656.
    PubMed     Text format     Abstract available

  12. ROSSINI PM, Cappa SF, Lattanzio F, Perani D, et al
    The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190670. doi: 10.3233/JAD-190670.
    PubMed     Text format     Abstract available

  13. KEHOE PG, Al Mulhim N, Zetterberg H, Blennow K, et al
    Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190721. doi: 10.3233/JAD-190721.
    PubMed     Text format     Abstract available

  14. MORSY A, Trippier PC
    Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 24. pii: JAD190744. doi: 10.3233/JAD-190744.
    PubMed     Text format     Abstract available

  15. TIAN J, Wang T, Wang Q, Guo L, et al
    MK0677, a Ghrelin Mimetic Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190779. doi: 10.3233/JAD-190779.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  16. LEE WJ, Liao YC, Wang YF, Lin YS, et al
    Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.
    J Am Geriatr Soc. 2019 Oct 6. doi: 10.1111/jgs.16181.
    PubMed     Text format     Abstract available


    J Neurol

  17. DOORDUIJN AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, et al
    Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared to controls: the NUDAD project.
    J Neurol. 2019 Oct 8. pii: 10.1007/s00415-019-09561.
    PubMed     Text format     Abstract available


    Nat Neurosci

  18. DUBE U, Del-Aguila JL, Li Z, Budde JP, et al
    An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
    Nat Neurosci. 2019 Oct 7. pii: 10.1038/s41593-019-0501.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  19. ANDREWS SJ, Goate A
    Mendelian randomization indicates that TNF is not causally associated with Alzheimer's disease.
    Neurobiol Aging. 2019 Sep 9. pii: S0197-4580(19)30323.
    PubMed     Text format     Abstract available

  20. TABATABAEI-JAFARI H, Shaw ME, Walsh E, Cherbuin N, et al
    Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume.
    Neurobiol Aging. 2019;83:86-94.
    PubMed     Text format     Abstract available

  21. TOSCHI N, Lista S, Baldacci F, Cavedo E, et al
    Biomarker-guided clustering of Alzheimer's disease clinical syndromes.
    Neurobiol Aging. 2019;83:42-53.
    PubMed     Text format     Abstract available

  22. LI P, Yu L, Yang J, Lo MT, et al
    Interaction between the progression of Alzheimer's disease and fractal degradation.
    Neurobiol Aging. 2019;83:21-30.
    PubMed     Text format     Abstract available

  23. KREMEN WS, Panizzon MS, Elman JA, Granholm EL, et al
    Pupillary dilation responses as a midlife indicator of risk for Alzheimer's disease: association with Alzheimer's disease polygenic risk.
    Neurobiol Aging. 2019;83:114-121.
    PubMed     Text format     Abstract available


    Neuropsychology

  24. GEURTEN M, Willems S, Salmon E, Bastin C, et al
    Fluency-based memory decisions in Alzheimer's disease: A matter of source detection?
    Neuropsychology. 2019 Oct 10. pii: 2019-60761-001. doi: 10.1037/neu0000605.
    PubMed     Text format     Abstract available


    PLoS One

  25. GUPTA Y, Lee KH, Choi KY, Lee JJ, et al
    Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images.
    PLoS One. 2019;14:e0222446.
    PubMed     Text format     Abstract available

  26. MUNOZ-CABRERA JM, Sandoval-Hernandez AG, Nino A, Baez T, et al
    Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer s disease.
    PLoS One. 2019;14:e0223578.
    PubMed     Text format     Abstract available

  27. SUDO FK, de Souza AS, Drummond C, Assuncao N, et al
    Inter-method and anatomical correlates of episodic memory tests in the Alzheimer's Disease spectrum.
    PLoS One. 2019;14:e0223731.
    PubMed     Text format     Abstract available

  28. JOSEPH DJ, Liu C, Peng J, Liang G, et al
    Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner.
    PLoS One. 2019;14:e0223509.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  29. SHARMA A, Kazim SF, Larson CS, Ramakrishnan A, et al
    Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1903566116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: